The drug was first approved for that purpose in 2017 and was then approved as a type 2 diabetes pill called Rybelsus and, most recently, as an injection to treat obesity called Wegovy
These observations are in contrast to previous findings in the same Nrf2-GFP-HepG2 reporter model exposed to DEM or tert -butylhydroquinone, which indicate a lower Nrf2 response toward repeated treatments (Bischoff et al
ACS Appl Mater interfaces
The gut (31) releases these factors due to food intake and plays an essential role in appetite regulation and body weight (32), decreasing hunger and nutrient intake (32, 33), and gastric emptying and gastrointestinal motility (29, 34)
Dangers One concern is the availability of BPC-157 as a research chemical, which raises quality and purity issues
GLP-1 analogues have become a clinician's best friend as they are able to maintain glycemic control and decrease hypoglycemia and the other risks as well as promote weight loss